When discounted playing cards will help alleviate the burden of superior drug expenses during the short term, they do not tackle the systemic problems driving up prescription costs within the U.S. Broader policy modifications could tackle the foundation brings about of growing drug rates, such as insufficient transparency in pricing plus the role o